Search for: "Teva USA" Results 261 - 280 of 714
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Jan 2013, 7:27 am by Lawrence B. Ebert
The agency said the problems appear to be associated with the Impax/Teva product.ANDThe U.S. [read post]
2 Jun 2011, 6:02 am by John Elwood
Teva Pharmaceuticals USA, Inc., 10-1070, which we included in last week’s Petitions to Watch. [read post]
17 Oct 2014, 7:23 am by Amy Howe
At Bloomberg View, Noah Feldman analyzes Wednesday’s oral argument in the patent case Teva Pharmaceuticals USA v. [read post]
20 Jun 2023, 7:37 pm by Patent Docs
Teva Pharmaceuticals USA, Inc. [read post]
28 Apr 2024, 8:18 pm by Patent Docs
Teva Pharmaceuticals USA, Inc. [read post]
20 Feb 2013, 7:37 am by Docket Navigator
Teva Pharmaceuticals USA Inc., et. al., 1-10-cv-00805 (DED February 11, 2013, Order) (Burke, M.J.). [read post]
15 Aug 2014, 7:08 am by Docket Navigator
Teva Pharmaceuticals USA, Inc. et al, 1-12-cv-08060 (NYSD August 13, 2014, Order) (Griesa, J.) [read post]
12 Apr 2017, 7:13 am by Docket Navigator
Teva Pharmaceuticals USA, Inc. et al, 2-15-cv-01455 (TXED April 10, 2017, Order) (Bryson, CJ) [read post]
19 Oct 2017, 10:29 am by Eric Caligiuri
Teva Pharmaceuticals USA, Inc. et al, Case No. 2:15-cv-1455-WCB (EDTX October 16, 2017 Order), a Federal District Court recently invalidated several patents covering Allergan’s dry-eye drug Restasis. [read post]
19 Oct 2017, 10:29 am by Eric Caligiuri
Teva Pharmaceuticals USA, Inc. et al, Case No. 2:15-cv-1455-WCB (EDTX October 16, 2017 Order), a Federal District Court recently invalidated several patents covering Allergan’s dry-eye drug Restasis. [read post]